MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...
Resources for observational comparative research have expanded enormously in recent years to include very large sources of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results